Source: Eur Respir Rev, 30 (162) 210124; 10.1183/16000617.0124-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Robert A. Wise, Mona Bafadhel, Courtney Crim, Gerard J. Criner, Nicola C. Day, David M.G. Halpin, MeiLan K. Han, Peter Lange, David A. Lipson, Fernando J. Martinez, Diego J. Maselli, Dawn Midwinter, Dave Singh, Maeva Zysman, Mark T. Dransfield, Richard E.K. Russell. Discordant diagnostic criteria for pneumonia in COPD trials: a review. Eur Respir Rev, 30 (162) 210124; 10.1183/16000617.0124-2021

Member's Comments

No comment yet.

Related content which might interest you: Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection. Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019 Definition, epidemiology and diagnostic criteria of IPF and how these guidelines were developed Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: evidence based guidelines and recommendations for clinical management - Results of the joint ATS/ERS/JRS taskforce Year: 2009 A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 Year: 2019 Useful malnutrition diagnostic criteria for stable COPD in Japanese patients Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Introduction: Evaluation criteria in clinical trials involving patients suffering from COPD Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003 Comparative study of clinical diagnostic criteria for ventilator-associated pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data Source: Eur Respir J 2014; 43: 842-851 Year: 2014 Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. Source: International Congress 2017 – Novel and old entities Year: 2017 Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis Source: International Congress 2017 – Management of COPD Year: 2017 Operational definitions of paediatric asthma used in epidemiological studies: A systematic review Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020 A systematic review of how patients value COPD outcomes Source: Eur Respir J, 52 (1) 1800222; 10.1183/13993003.00222-2018 Year: 2018 Pulmonary hypertension in COPD patients: a systematic review and meta-analysis Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs) Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials Source: ERJ Open Res, 5 (1) 00147-2018; 10.1183/23120541.00147-2018 Year: 2019 Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Source: Guideline 2004 Year: 2004 Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Source: Eur Respir J 2004; 23: 932-946 Year: 2004 Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials Source: International Congress 2017 – COPD management Year: 2017